ArTS Archivio della ricerca di Trieste

LUCAFÒ, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.341
EU - Europa 3.530
AS - Asia 1.229
AF - Africa 34
SA - Sud America 31
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 9.174
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.322
PL - Polonia 1.297
IT - Italia 848
CN - Cina 418
SE - Svezia 393
SG - Singapore 357
HK - Hong Kong 288
DE - Germania 223
RU - Federazione Russa 155
FI - Finlandia 116
UA - Ucraina 101
BG - Bulgaria 69
IE - Irlanda 69
FR - Francia 68
TR - Turchia 56
GB - Regno Unito 40
BE - Belgio 39
VN - Vietnam 29
SN - Senegal 27
NL - Olanda 25
KR - Corea 24
BR - Brasile 21
JP - Giappone 15
AT - Austria 14
CA - Canada 14
IN - India 12
CH - Svizzera 11
CZ - Repubblica Ceca 10
ES - Italia 9
GR - Grecia 8
PK - Pakistan 8
RS - Serbia 6
SI - Slovenia 6
AR - Argentina 5
HU - Ungheria 5
MY - Malesia 5
AU - Australia 4
CL - Cile 4
EU - Europa 4
EG - Egitto 3
HR - Croazia 3
IL - Israele 3
LT - Lituania 3
MD - Moldavia 3
PH - Filippine 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
GH - Ghana 2
ID - Indonesia 2
KW - Kuwait 2
LB - Libano 2
MT - Malta 2
MX - Messico 2
NO - Norvegia 2
A1 - Anonimo 1
CU - Cuba 1
GE - Georgia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
NG - Nigeria 1
PE - Perù 1
SA - Arabia Saudita 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 9.174
Salva come PNG Salva come JPEG
Città #
Warsaw 1.290
Fairfield 563
Chandler 451
Woodbridge 428
Trieste 363
Ashburn 347
Ann Arbor 326
Singapore 305
Houston 293
Hong Kong 277
Wilmington 253
Seattle 242
Cambridge 173
Jacksonville 120
Princeton 110
Boardman 108
Munich 107
Beijing 80
Moscow 73
Helsinki 70
Sofia 69
Dublin 65
Santa Clara 64
Columbus 63
Dearborn 55
Izmir 42
Milan 40
Brussels 36
Dakar 27
Dong Ket 26
Falls Church 23
Redwood City 23
San Diego 23
Shanghai 22
Seoul 20
Guangzhou 19
Lappeenranta 16
Rome 16
Bremen 15
Dallas 14
Des Moines 14
Hefei 13
Los Angeles 13
Udine 13
Jinan 12
Vienna 12
Nanjing 11
Venice 11
Brno 10
Mestre 10
Shenyang 10
Washington 10
Bern 9
Redmond 9
Amsterdam 8
Bologna 8
Chengdu 8
Kocaeli 8
Kunming 8
Norwalk 8
Changsha 7
Chicago 7
Fano 7
Nuremberg 7
Paris 7
Phoenix 7
Pignone 7
Scafati 7
Hebei 6
Macclesfield 6
Monfalcone 6
Zhengzhou 6
Ariano Irpino 5
Belgrade 5
Brooklyn 5
Budapest 5
Düsseldorf 5
Florence 5
Fogliano Redipuglia 5
Hangzhou 5
Islamabad 5
Krakow 5
London 5
Nanchang 5
Pátrai 5
São Paulo 5
Torre Del Greco 5
Boulder 4
Edinburgh 4
Fremont 4
Guangdong 4
Guelph 4
Haikou 4
Lanzhou 4
Ljubljana 4
Palm City 4
Pune 4
Sesto al Reghena 4
Shenzhen 4
Toronto 4
Totale 7.069
Salva come PNG Salva come JPEG
Nome #
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 408
Pharmacogenetics of thiopurines 384
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 382
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 364
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 334
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 330
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 322
Identification and Characterization of a Novel Family of Cysteine-Rich Peptides (MgCRP-I) from Mytilus galloprovincialis 288
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 251
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 236
A Cationic [60] Fullerene Derivative Reduces Invasion and Migration of HT-29 CRC Cells in Vitro at Dose Free of Significant Effects on Cell Survival 229
Pharmacogenetics of treatments for inflammatory bowel disease 225
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease 214
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 210
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 204
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 198
Pro-inflammatory effects of palytoxin: An: in vitro study on human keratinocytes and inflammatory cells 183
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 176
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. 174
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 170
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 166
Hydrophilic polymer coated monodispersed Fe3O4 nanostructures and their cytotoxicity 164
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 161
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A 157
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 146
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 145
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 144
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 144
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 136
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 132
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance 132
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 131
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 129
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 127
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5 125
MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY 100
Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa 89
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway 88
Microbiota and drug response in inflammatory bowel disease 83
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 80
Sedation and analgesia in children with cerebral palsy: a narrative review 79
Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook 77
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients 76
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 74
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 74
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 73
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease 73
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 73
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 71
Patient-derived organoids for therapy personalization in inflammatory bowel diseases 69
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency 69
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention 69
Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease 62
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells 62
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease 60
Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5 57
A patent review of anticancer glucocorticoid receptor modulators (2014-present) 57
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease 57
Pharmacogenomics of antibiotics 53
Clinical application of thiopurine pharmacogenomics in pediatrics 51
iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy 50
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 46
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 45
Preanalytical Stability of 13 Antibiotics in Biological Samples: A Crucial Factor for Therapeutic Drug Monitoring 42
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells 40
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report 39
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease 34
The long non-coding RNA GAS5 contributes to the suppression of inflammatory responses by inhibiting NF-κB activity 19
Neuron-Derived Extracellular Vesicles miRNA Profiles Identify Children Who Experience Adverse Events after Ketamine Administration for Procedural Sedation 16
Time-efficient strategies in human iPS cell-derived pancreatic progenitor differentiation and cryopreservation: advancing towards practical applications 15
Monoclonal antibodies against pediatric ulcerative colitis: a review of clinical progress 14
Totale 9.557
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020984 0 0 0 0 0 0 248 201 190 125 137 83
2020/20211.422 126 110 126 116 164 161 159 69 92 137 62 100
2021/2022901 63 51 54 80 40 85 78 28 100 89 36 197
2022/20231.324 120 215 94 197 115 209 15 119 129 27 48 36
2023/2024989 48 51 37 47 87 96 180 206 31 34 111 61
2024/20251.369 43 153 234 240 215 324 160 0 0 0 0 0
Totale 9.557